Effects of photobiomodualtion therapy on breast cancer-related lymphoedema: A systematic review and meta-analysis of randomised controlled trials

Hsuan Yu Chen, Hui Hsuan Tsai, Ka Wai Tam, Tsai Wei Huang

Research output: Contribution to journalReview article

Abstract

Objective: Lymphoedema characterised by the persistent accumulation of the interstitial fluid in peripheral tissues post breast cancer treatments. Photobiomodualtion therapy (PBMT) is widely used as supportive care in patients with breast cancer or breast cancer-related lymphoedema (BCRL). This systematic review and meta-analysis analysed the effectiveness and safety of PBMT for the treatment of BCRL. Method: PubMed, EMBASE, PEDro, SCOPUS, CINAHL, and Cochrane Central Register of Controlled Trials were searched for RCTs on PBMT published before July 2019. Randomised controlled trials (RCTs) that evaluated the efficacy of PBMT on BCRL were included. The primary outcome was the arm circumference or volume, and secondary outcomes were grip strength and pain scores. This study is registered with PROSPERO (number CRD 42018102107). Results: We reviewed nine RCTs that included 316 patients and six studies for mata-analysis. We found no significant difference in the reduction of the arm circumference or arm volume after treatment, one month, and three month follow-up between the PBMT and control groups. Studies revealed no significant differences in the reduction in grip strength and pain scores at 0, 1, 2, and 3 month between the PBMT and control groups. Conclusions: Although PBMT demonstrated a slight improvement in reducing arm circumference and arm volume, the results of our meta-analysis did not show significant benefits in relieving of lymphoedema. Further trials are needed to recruit more participants, and to evaluate the long-term efficacy and safety of PBMT in management of breast cancer-related lymphoedema.

Original languageEnglish
Article number102200
JournalComplementary Therapies in Medicine
Volume47
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Meta-Analysis
Randomized Controlled Trials
Therapeutics
Lymphedema
Hand Strength
Breast Neoplasms
Breast Cancer Lymphedema
Safety
Pain
Control Groups
Extracellular Fluid
PubMed
Patient Care

Keywords

  • Breast cancer
  • Low-level laser therapy
  • Lymphoedema
  • Meta-analysis
  • Photobiomodualtion therapy

ASJC Scopus subject areas

  • Complementary and Manual Therapy
  • Complementary and alternative medicine
  • Advanced and Specialised Nursing

Cite this

@article{1a87f767d6b9406a91c35b5d6c60c267,
title = "Effects of photobiomodualtion therapy on breast cancer-related lymphoedema: A systematic review and meta-analysis of randomised controlled trials",
abstract = "Objective: Lymphoedema characterised by the persistent accumulation of the interstitial fluid in peripheral tissues post breast cancer treatments. Photobiomodualtion therapy (PBMT) is widely used as supportive care in patients with breast cancer or breast cancer-related lymphoedema (BCRL). This systematic review and meta-analysis analysed the effectiveness and safety of PBMT for the treatment of BCRL. Method: PubMed, EMBASE, PEDro, SCOPUS, CINAHL, and Cochrane Central Register of Controlled Trials were searched for RCTs on PBMT published before July 2019. Randomised controlled trials (RCTs) that evaluated the efficacy of PBMT on BCRL were included. The primary outcome was the arm circumference or volume, and secondary outcomes were grip strength and pain scores. This study is registered with PROSPERO (number CRD 42018102107). Results: We reviewed nine RCTs that included 316 patients and six studies for mata-analysis. We found no significant difference in the reduction of the arm circumference or arm volume after treatment, one month, and three month follow-up between the PBMT and control groups. Studies revealed no significant differences in the reduction in grip strength and pain scores at 0, 1, 2, and 3 month between the PBMT and control groups. Conclusions: Although PBMT demonstrated a slight improvement in reducing arm circumference and arm volume, the results of our meta-analysis did not show significant benefits in relieving of lymphoedema. Further trials are needed to recruit more participants, and to evaluate the long-term efficacy and safety of PBMT in management of breast cancer-related lymphoedema.",
keywords = "Breast cancer, Low-level laser therapy, Lymphoedema, Meta-analysis, Photobiomodualtion therapy",
author = "Chen, {Hsuan Yu} and Tsai, {Hui Hsuan} and Tam, {Ka Wai} and Huang, {Tsai Wei}",
year = "2019",
month = "12",
day = "1",
doi = "10.1016/j.ctim.2019.102200",
language = "English",
volume = "47",
journal = "Complementary Therapies in Medicine",
issn = "0965-2299",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Effects of photobiomodualtion therapy on breast cancer-related lymphoedema

T2 - A systematic review and meta-analysis of randomised controlled trials

AU - Chen, Hsuan Yu

AU - Tsai, Hui Hsuan

AU - Tam, Ka Wai

AU - Huang, Tsai Wei

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Objective: Lymphoedema characterised by the persistent accumulation of the interstitial fluid in peripheral tissues post breast cancer treatments. Photobiomodualtion therapy (PBMT) is widely used as supportive care in patients with breast cancer or breast cancer-related lymphoedema (BCRL). This systematic review and meta-analysis analysed the effectiveness and safety of PBMT for the treatment of BCRL. Method: PubMed, EMBASE, PEDro, SCOPUS, CINAHL, and Cochrane Central Register of Controlled Trials were searched for RCTs on PBMT published before July 2019. Randomised controlled trials (RCTs) that evaluated the efficacy of PBMT on BCRL were included. The primary outcome was the arm circumference or volume, and secondary outcomes were grip strength and pain scores. This study is registered with PROSPERO (number CRD 42018102107). Results: We reviewed nine RCTs that included 316 patients and six studies for mata-analysis. We found no significant difference in the reduction of the arm circumference or arm volume after treatment, one month, and three month follow-up between the PBMT and control groups. Studies revealed no significant differences in the reduction in grip strength and pain scores at 0, 1, 2, and 3 month between the PBMT and control groups. Conclusions: Although PBMT demonstrated a slight improvement in reducing arm circumference and arm volume, the results of our meta-analysis did not show significant benefits in relieving of lymphoedema. Further trials are needed to recruit more participants, and to evaluate the long-term efficacy and safety of PBMT in management of breast cancer-related lymphoedema.

AB - Objective: Lymphoedema characterised by the persistent accumulation of the interstitial fluid in peripheral tissues post breast cancer treatments. Photobiomodualtion therapy (PBMT) is widely used as supportive care in patients with breast cancer or breast cancer-related lymphoedema (BCRL). This systematic review and meta-analysis analysed the effectiveness and safety of PBMT for the treatment of BCRL. Method: PubMed, EMBASE, PEDro, SCOPUS, CINAHL, and Cochrane Central Register of Controlled Trials were searched for RCTs on PBMT published before July 2019. Randomised controlled trials (RCTs) that evaluated the efficacy of PBMT on BCRL were included. The primary outcome was the arm circumference or volume, and secondary outcomes were grip strength and pain scores. This study is registered with PROSPERO (number CRD 42018102107). Results: We reviewed nine RCTs that included 316 patients and six studies for mata-analysis. We found no significant difference in the reduction of the arm circumference or arm volume after treatment, one month, and three month follow-up between the PBMT and control groups. Studies revealed no significant differences in the reduction in grip strength and pain scores at 0, 1, 2, and 3 month between the PBMT and control groups. Conclusions: Although PBMT demonstrated a slight improvement in reducing arm circumference and arm volume, the results of our meta-analysis did not show significant benefits in relieving of lymphoedema. Further trials are needed to recruit more participants, and to evaluate the long-term efficacy and safety of PBMT in management of breast cancer-related lymphoedema.

KW - Breast cancer

KW - Low-level laser therapy

KW - Lymphoedema

KW - Meta-analysis

KW - Photobiomodualtion therapy

UR - http://www.scopus.com/inward/record.url?scp=85072692926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072692926&partnerID=8YFLogxK

U2 - 10.1016/j.ctim.2019.102200

DO - 10.1016/j.ctim.2019.102200

M3 - Review article

AN - SCOPUS:85072692926

VL - 47

JO - Complementary Therapies in Medicine

JF - Complementary Therapies in Medicine

SN - 0965-2299

M1 - 102200

ER -